Bilastine safety in drivers who need antihistamines: new evidence from high-speed simulator driving test on allergic patients.
CONCLUSIONS: This study is the first done in patients with allergic rhinitis and/or chronic urticaria using a F1-high speed simulator-driving test evaluating subjects' performance under bilastine treatment.
PMID: 29461615 [PubMed - in process]
Source: European Review for Medical and Pharmacological Sciences - Category: Drugs & Pharmacology Tags: Eur Rev Med Pharmacol Sci Source Type: research
More News: Allergy & Immunology | Drugs & Pharmacology | Hay Fever | Hives | Laboratory Medicine | Study